Emerald Mutual Fund Advisers Trust Guardant Health, Inc. Transaction History
Emerald Mutual Fund Advisers Trust
- $1.75 Billion
- Q3 2025
A detailed history of Emerald Mutual Fund Advisers Trust transactions in Guardant Health, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 556,009 shares of GH stock, worth $52.5 Million. This represents 1.99% of its overall portfolio holdings.
Number of Shares
556,009
Previous 415,774
33.73%
Holding current value
$52.5 Million
Previous $21.6 Million
60.56%
% of portfolio
1.99%
Previous 1.47%
Shares
3 transactions
Others Institutions Holding GH
# of Institutions
449Shares Held
125MCall Options Held
2.18MPut Options Held
2.69M-
Vanguard Group Inc Valley Forge, PA11.9MShares$1.12 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$1.06 Billion0.01% of portfolio
-
Baillie Gifford & CO5.13MShares$484 Million0.25% of portfolio
-
Invesco Ltd. Atlanta, GA4.93MShares$465 Million0.05% of portfolio
-
Capital International Investors Los Angeles, CA4.69MShares$443 Million0.05% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $9.65B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...